Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
Indiatimes16h
Usha Martin Education & Solutions Share Price
Usha Martin Education & Solutions Ltd., incorporated in the year 1997, is a Small Cap company (having a market cap of Rs 14.61 Crore) operating in Learning & Education sector. Usha Martin Education & ...